NEKTAR THERAPEUTICS

CUSIP: 640268108 Class: Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,471,237 Value ($000) $1,368 Avg Close — Range —
Q4 2023
Shares 2,386,241 Value ($000) $1,336 Avg Close — Range —
Q3 2023
Shares 2,936,218 Value ($000) $1,762 Avg Close — Range —
Q1 2023
Shares 53,900 Value ($000) $38 Avg Close — Range —
Q3 2022
Shares 31,144 Value ($000) $100 Avg Close — Range —
Q4 2021
Shares 36,643 Value ($000) $495 Avg Close — Range —
Q2 2021
Shares 88,751 Value ($000) $1,523 Avg Close — Range —
Q4 2019
Shares 84,520 Value ($000) $1,825 Avg Close — Range —
Q1 2019
Shares 123,717 Value ($000) $4,156 Avg Close — Range —
Q4 2018
Shares 185,608 Value ($000) $6,101 Avg Close — Range —
Q1 2018
Shares 7,291 Value ($000) $775 Avg Close — Range —
Q2 2017
Shares 21,444 Value ($000) $429 Avg Close — Range —
Q4 2016
Shares 829,982 Value ($000) $10,184 Avg Close — Range —
Q3 2016
Shares 598,207 Value ($000) $10,277 Avg Close — Range —
Q2 2016
Shares 238,180 Value ($000) $3,389 Avg Close — Range —
Q4 2015
Shares 324,124 Value ($000) $5,462 Avg Close — Range —
Q3 2014
Shares 79,904 Value ($000) $964 Avg Close — Range —